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ABSTRACT
The  effects of cortisone  treatment on  oxygen  consumption,  oxidative  phosphorylation,  and
fine structure  of rat liver mitochondria  have  been studied.  Male  rats weighing  125 g were
treated  for 6 days with 5 mg of cortisone acetate or isotonic  saline. On the  7th  day, sections
of liver were excised  and processed for light and electron microscopy.  Mitochondrial respira-
tion  and  oxidative  phosphorylation  were  studied  with  mitochondria  isolated  from  these
livers.  Cortisone treatment  is  responsible  for  a  14-40%  decrease  in  the amount  of oxygen
consumed  per mg of mitochondrial  protein when  succinate,  a-ketoglutarate,  or j-hydroxy-
butyrate  are used as substrates, or with ascorbate and N ,N, N  ,NI-tetramethyl p-phenylene-
diamine  as  electron  donors.  In  addition,  oxidative  phosphorylation  is  uncoupled  with  a
lowering of the P :O ratios. Randomly selected  liver cells have been analyzed  by quantitative
morphometric  techniques.  The  average  mitochondrial  volume  is increased  fourfold  in the
peripheral  and  midzonal  regions  with  a commensurate  decrease  in  the  number  of mito-
chondria per cell. These alterations are present throughout the hepatic lobule,  but are most
marked  in midzonal  cells. The total  mitochondrial volume per cell and  the per cent of the
total  cytoplasmic  volume  occupied  by mitochondria  remains  relatively  unaltered,  as does
the total  amount of cristae  surface  per  cell.  While the mitochondria  are  enlarged,  they are
not "swollen."  The relationships between the steroid  hormone treatment and the alterations
in mitochondrial  function and  structure are discussed.
It  has  long  been  recognized  that  cortisone  ad-
ministration produces  a multitude of physiological
and  biochemical  alterations.  Cortisone  has,  for
example,  been  shown  to  alter  the  activity  in  the
liver of certain  enzymes  involved  in carbohydrate
metabolism  (1),  and,  in addition,  may  affect  the
rate of synthesis  of nucleic  acids,  certain  enzymes,
and other proteins  (2,  3).  The mechanisms  under-
lying these diverse  hormonal effects are still poorly
understood.
Mitochondrial respiration, oxidative phosphoryl-
ation,  and  ion  translocation  are  of  obvious  im-
portance  in  cell  metabolism,  and  a  number  of
studies have been  concerned  with  the influence  of
glucocorticoid  treatment on  these  aspects  of mito-
chondrial  function  (4-10).  While these  earlier re-
ports suggested  that  cortisone  treatment in the rat
may alter the number, size,  and  biochemical  func-
tion of  liver  mitochondria,  there has  been uncer-
tainty about the precise nature of these steroid hor-
mone  effects.
The present studies were undertaken  in an effort
to define more clearly the effects of cortisone  treat-
ment on  rat liver mitochondrial  oxygen  consump-
tion, oxidative phosphorylation, and fine structure.
The results demonstrate that treatment with corti-
sone  causes  multiple  defects  in the  mitochondrial
respiratory  chain  and  uncouples  oxidative  phos-
63phorylation.  Cortisone  treatment,  in  addition,
results  in  a  striking  decrease  in  the  number  of
mitochondria  per liver  cell along with an increase
in  the  average  mitochondrial  volume.  The  total
mitochondrial  volume per  liver cell,  however,  re-
mains  relatively unaltered.
MATERIALS  AND  METHODS
Most of the chemicals  used in the incubation  mixtures
and  in  the  inorganic  phosphate  and protein  deter-
minations  were  of  analytical  grade  and  were  pur-
chased from the usual commercial sources.  Coenzyme
Q-6,  coenzyme  Q-10  (beef  heart),  and  d-alpha-
tocopherol  were  purchased  from  Mann  Research
Laboratories,  Inc.,  New  York,  and  were  emulsified
for  use  according  to the  method of Nason  and  Leh-
man  (11).  Antimycin  A, rotenone,  and  Amytal were
generously  provided  by  Ayerst  Laboratories,  Inc.,
New  York,  S.  B.  Pennick  and  Co.,  New  York,  and
Eli  Lilly  and  Co.,  Indianapolis,  respectively.  Corti-
sone and  hydrocortisone  were obtained from Merck,
Sharp, and Dohme, West  Point, Pa.  (Cortone acetate
and  Hydrocortone  acetate,  both  25  mg  per  ml  in
saline  suspension).  Prednisolone  was purchased  from
the  Schering  Corp.,  Bloomfield,  N.J.  (Meticortelone
acetate,  25 mg per  ml in aqueous  suspension).
Albino male rats  of the  Columbia-Sherman  strain
were  obtained  at a  weight  of  125  g  and fed a  stock
laboratory  diet ad libitum. The animals were injected
subcutaneously  with  either 5 mg of cortisone acetate,
3  mg of hydrocortisone  acetate,  or  1 mg of predniso-
lone  acetate  daily  for  6  days  with  control  animals
receiving  injections  of  the  appropriate  vehicle.  On
the 7th day two or more control and an equal number
of the  steroid-treated  animals  were  killed  by  a blow
to the  head followed  by decapitation.
Measurement  of  Mitochondrial  Respiration
and Oxidative Phosphorylation
Mitochondrial  suspensions  were prepared from the
livers  of both  the control  and steroid-treated  animals
as  previously  described  (9).  The  mitochondrial
suspensions were diluted with 0.25 M  sucrose so that a
0.1  ml  aliquot  of  each  gave  the  same  absorbance
reading  at  520  mp  when  added  to 4.4  ml  of  0.5  M
sucrose  containing  0.017  M Tris-HCI,  pH  7.4.  The
final concentrations  were between  3.4 and 14.2 mg of
protein  per  ml,  measured  by  a modification  of  the
biuret  procedure  (12).  The  protein  values  for  the
suspensions  of mitochondria from control  and treated
animals  in any  single  experiment  agreed  to  within
10%  and  are indicated  in the legends.
Oxygen  consumption  was determined  manometri-
cally  with  a  Warburg  apparatus  (13).  The  system
used for the  assay of oxidative  phosphorylation  con-
tained  (with  individual  variations  indicated  in  the
legends)  10-20  mM  substrate,  10.6  mM  pH  7.4 potas-
sium  phosphate buffer,  208  mM  sucrose,  2  mM  ATP,
5  mM  MgSO 4,  0.013  mM  cytochrome  c,  16.6  mM
glucose,  and 0.6  mg of hexokinase  in a total  volume
of 3 ml,  including 0.5  ml of mitochondria  suspension
equivalent  to  1.7-7.1  mg  of protein.  The  flasks were
incubated  at  30
0C  with  air  as  the  gas  phase  for  a
period of 20-40 min following  a 10-min equilibration
period.  The  center  wells  contained  0.2  ml  of  10  N
KOH  absorbed  on  fluted  filter  paper.  Following  a
period  of  equilibration,  the  hexokinase  and  glucose
were  tipped  in from  the side arm.  The reaction  was
stopped  by  chilling  the  flasks,  followed  by the  rapid
addition  of  0.2  ml  of  50%  trichloroacetic acid.  In-
organic  phosphate  was  determined  on  the  superna-
tant  solution  by  the  procedure  of Fiske  and  Subba-
Row  (14).  The  results  of the experiments  on oxygen
consumption and oxidative phosphorylation represent
the  mean  values  obtained  in  four  or  more  separate
experiments  performed  in the same  manner.
Electron Microscopy
A  quantitative  morphometric  analysis  of  intra-
mitochondrial  structure  in  control  and  cortisone-
treated  rats  was  done  as  previously  described  for
normal liver mitochondria  (15). Random thin sections
were cut from blocks of glutaraldehyde-  and osmium-
tetroxide  fixed  livers  from  the  same  animals  that
were  used  in a  parallel  study  of cortisone  effects  on
whole  liver  cell  ultrastructure  (16).  A  total  of  40
electron  micrographs  showing  cross-sections of  mito-
chondria were analyzed  at a magnification  of 50,000.
These  represented  a  minimum  of two  tissue  blocks
from  each  of the  peripheral,  midzonal,  and  central
regions  of liver  lobules  in  each  of  two  control  and
three cortisone-injected  rats.
Liver  mitochondria  from  control  and  cortisone-
treated  rats  were  isolated  in  0.25  M sucrose  in  the
same  manner as that used for the biochemical  studies
and were fixed as pellets for 3 hr in pH 7.4 phosphate-
buffered  glutaraldehyde,  postfixed  in  2%  osmium
tetroxide with added  sucrose,  dehydrated in acetone,
and embedded in Araldite.  Sections from the bottom,
middle,  and top of each pellet were compared  in the
electron  microscope.  Isolated mitochondria were also
examined in negatively stained preparations with 2%
phosphotungstic  acid  adjusted to pH 6.8 with  KOH
(17).
RESULTS
Mitochondrial  Respiration  and
Oxidative  Phosphorylation
Cortisone  treatment  in  the  rat,  as  shown  in
Table I, is responsible for a 14-40 % decrease in the
amount of oxygen  consumed  per mg of mitochon-
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Effect  of Cortisone Treatment on Mitochondrial Oxygen Consumption and Oxidative Phosphorylation
pAtoms  02  Consumed/mg  Protein  P:O  Ratio
Substrate  Control  Treated  p  Control  Treated  p
ca-Ketoglutarate  1.0  0.6  <0.01  3.0  1.5  <0.01
/3-Hydroxybutyrate  1.4  0.9  <0.01  2.3  1.7  <0.01
Succinate  2.9  2.5  <0.02  1.6  1.3  <0.01
Ascorbate  +  TMPD  2.5  1.8  <0.02  1.0  0.7  <0.01
The  experiments  were  performed  as  described  in  the  text.  The  flasks  contained  10.6  mM  potassium
phosphate buffer,  pH  7.4,  208 mM  sucrose,  2  mM ATP,  5  mM MgSO 4,  16.6  mM  glucose,  and 0.6  mg of
hexokinase.  In experiments with a-ketoglutarate,  the substrate was present  in a concentration  of 10  mM
along with  5  mM malonate  and 0.013 mM  cytochrome  c.  The flasks  contained between  5.5 and 7.1  mg  of
mitochondrial  protein and were  incubated for 30 min following  equilibration.  In experiments with d,  1 S-
hydroxybutyrate,  the substrate was  present in a concentration of 20 mM along with 0.013 mM  cytochrome c.
The flasks,  which contained between  3.9 and 4.9 mg of mitochondrial  protein,  were incubated for 30 min
following equilibration. The experiments with succinate were conducted with  10  mm substrate,  0.013  mM
cytochrome  c,  1.7 to 2.5 mg of mitochondrial protein  per flask, and an incubation period of 20 min  follow-
ing equilibration.  Ascorbate  and TMPD were  present in  concentrations  of 11.4 and 0.22 mM respectively,
along with 0.67  mg of antimycin  A and 5.8  mg of mitochondrial  protein per flask.  The  incubations  were
carried  out  for 20  min following  equilibration.
drial  protein  when  either  a-ketoglutarate,  ,B-
hydroxybutyrate,  or  succinate  are  used  as  sub-
strates,  or  with  ascorbate  and  N,N,N',N'-tetra-
methyl  p-phenylenediamine  (TMPD)  as  electron
donors.  In  addition,  oxidative  phosphorylation  is
uncoupled,  with  a  lowering  of  the  P:O  ratio
following  cortisone  treatment. Liver mitochondria
prepared from animals treated with hydrocortisone
and  prednisolone  were  found  to  exhibit  a  similar
inhibition  of  oxygen  consumption  as  well  as  a
lowering of the P:  O ratio.
Ascorbate  and  TMPD,  as  shown  in  Fig.  1,
interact  with  the respiratory  chain  at the  level  of
cytochrome  c  (18).  In  the  presence  of  both
rotenone  and  antimycin  A,  inhibitors  of electron
transport,  only the cytochrome  c-to-O2  segment  of
the respiratory  chain and its associated phosphoryl-
ation  site  are  active.  The fact  that the oxidation
of ascorbate  and  TMPD  is  inhibited  under  these
conditions  in  mitochondria from cortisone-treated
rats (Table I), indicates the presence of at least one
defect  in  the  terminal  portion  of  the  respiratory
chain. This single defect could possibly explain  the
decrease  in  oxygen  consumption  noted  with  the
other substrates. The following studies were under-
taken  in  an  effort  to  explore  the  possibility  of
additional  sites  of inhibition of electron  transport.
Antimycin A inhibits the respiratory chain at the
level of cytochrome  b  (Fig.  1)  (19).  Experiments
were  performed  with  0-hydroxybutyrate  or  suc-
cinate  as the substrate in the presence and absence
of  varying  concentrations  of  antimycin  A.  As
shown  in Table  II,  antimycin  A,  at a concentra-
tion  of  1.6  X  10-2  g per mg of mitochondrial pro-
tein, has little effect on either the oxygen consump-
tion or the P:O ratio in mitochondria isolated from
control  animals. On the other hand,  mitochondria
isolated  from  cortisone-treated  animals  are
markedly  affected  by  this  low  concentration  of
antimycin A, with an 82 % decrease in the amount
of oxygen consumed  per mg of mitochondrial  pro-
tein. It would thus appear that cortisone treatment
potentiates or decreases the threshold for the effects
of antimycin A, a finding suggesting the possibility
of an additional inhibitory effect on electron trans-
port at, or near the antimycin-sensitive  step.
Fig.  1 shows  the  site  of action  of rotenone  and
Amytal, both of which inhibit the respiratory chain
at an early locus in the vicinity of NADH  oxidase,
the  flavoprotein-bearing  carrier  (20,  21).  Experi-
ments were performed  with mitochondria from the
livers  of control  and  cortisone-treated  animals  in
which $-hydroxybutyrate was used as the substrate
in  the presence  and absence  of varying  concentra-
tions of rotenone  and Amytal. As seen in Table III,
a concentration of rotenone (2.5  X  0- a ug per mg
of mitochondrial  protein)  which inhibited  respira-
tion  in  the  control  mitochondria  by  14%  had  a
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FIGURE  1  Schematic  representation  of the respiratory  chain indicating  the sites  at which  inhibitors  of electron
transport act. The steps  are  shown  in  which  the  oxidation-reduction  dyes  used  in  this  study  accept  electrons
or  donate  them  to  the electron  transport  chain.  The  sites  of  energy  conservation  for  oxidative  phosphoryla-
tion  are  indicated  with  Roman  numerals.  NADH,  reduced  diphosphopyridine  nucleotide;  FPH 2,  reduced
flavoprotein;  PMS,  phenazine  methosulfate;  TMPD,  N,N,N',N'  tetramethyl  p-phenylenediamine;  ATP,
adenosine triphosphate.
TABLE  II
Effect  of Cortisone Treatment on Mitochondrial Oxygen Consumption and Oxidative Phosphorylation  Measured in the
Presence and Absence of Antimycin  A
/uAtoms  02  Consumed/mg  Protein  P:O Ratio
Antimycin  A 
ug/mg  Protein  Control  Treated  p  Control  Treated  p
None  1.3  0.9  <0.01  2.4  1.8  <0.01
1.6  X  10-2  1.1  0.2  <0.01  2.1  0.3  <0.01
The experiments were performed as described in the text and in the legend for Table I. In these experi-
ments  with  d,  I  /-hydroxybutyrate,  the substrate was present  in  a concentration  of 23  m  along  with
0.013 mM cytochrome  c and either 0.1  ml of ethanol or antimycin A in ethanol. The flasks, which contained
between 4.5 and 4.9 mg of mitochondrial protein,  were incubated for 30 min following  equilibration.
similar  small  inhibitory  effect  on  respiration  in
mitochondria  from  the  cortisone-treated  animals.
At no  concentration  of either rotenone  or Amytal
was  there  a  selective  or  preferential  inhibition  of
respiration  in  mitochondria  isolated  from  the
cortisone-treated  animals.
Referring  to Fig.  I  again,  it  is  seen  that phena-
zine  methosulfate  (I  mmn) can  carry  electrons  to
oxygen  by  a  route  that  is  insensitive  to  Amytal,
rotenone,  antimycin  A,  and  cyanide,  thus  by-
passing  all  but  early  segments  of the  respiratory
chain (22). Table IV presents the results  of experi-
ments  in  which respiration  in  liver mitochondria
from  control  and  cortisone-treated  animals  was
blocked  by  Amytal,  antimycin  A,  and  cyanide,
using  -hydroxybutyrate  as  the  substrate.  In  the
absence of phenazine methosulfate  there  is neither
respiration nor phosphorylation.  In  the presence of
the  phenazine  methosulfate  bypass  the  rate  of
respiration  with  mitochondria  from  the  steroid-
treated animals  is one-half that of the control rate.
Again,  as  anticipated  with the bypass  of the phos-
phorylation  sites,  there  is no  net uptake  of phos-
phate.  It,  therefore,  appears probable  that there is
a third  site  of steroid-related  inhibition of respira-
tion prior to the site of the phenazine  methosulfate
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Effect of Cortisone Treatment on Mitochondrial Oxygen  Consumption and Oxidative Phosphorylation  Measured in the
Presence and Absence of Rotenone
/Atoms  02  Consumed/mg  Protein  P:O Ratio
Rotenone
/Ag/mg  Protein  Control  Treated  p  Control  Treated  p
None  1.4  0.9  <0.01  2.5  2.0  <0.01
2.5  X  10
-3 1.2  0.8  <0.01  2.4  2.0  <0.01
3.9  X  10-3  0.9  0.6  <0.02  2.4  2.0  <0.02
The experiments were performed  as described in the text and in the legend for Table I. In these experi-
ments with d,  I  3-hydroxybutyrate, the substrate  was present  in  a  concentration  of 20 mM  along with
0.013  mM cytochrome  c and either  0.1  ml  of ethanol or rotenone in ethanol.  The flasks, which contained
5 mg of mitochondrial  protein, were incubated for 30 min following  equilibration.
TABLE  IV
Effect  of Cortisone Treatment on Mitochondrial Oxygen Consumption  Localization of Sites of Inhibition
/Atoms  02 Consumed/mg  Protein  P:O  Ratio
Phenazine
Methosulfate  Control  Treated  p  Control  Treated  p
None  0.0  0.0  0.0  0.0
1 X  10-3 M  0.6  0.3  <0.02  0.0  0.0  -
The experiments  were performed as described in the text and in the legend for Table I.  In these experi-
ments with  d,  I  -hydroxybutyrate, the substrate  was  present  in  a concentration  of 20  mM  along  with
1 mM Amytal,  1.5 mM NaCN, and 0.99 Mg  of antimycin A per ml. The Amytal and antimycin A were  added
in  a total  volume  of 0.09 ml  of ethanol per flask. When  added, phenazine  methosulfate  was  present in a
concentration  of 1 mM.  The flasks,  which contained  between 5.8  and 6.0 mg  of mitochondrial  protein,
were  incubated for 20 min  following equilibration.
bypass. This  inhibition could  be at the  level of /-
hydroxybutyrate  dehydrogenase  or  in  the  early
portion of the electron-transport  sequence.
The addition  in vitro of diethylstilbestrol,  estra-
diol,  corticosterone,  deoxycorticosterone,  proges-
terone,  testosterone,  and  other  steroid  hormones
has been found  to  be associated  with inhibition  of
NADH  oxidase  activity  in  preparations  from  a
variety  of mammalian  and  microbial sources  (23-
26).  Yielding  et  al.  provided  evidence  that  the
diethylstilbestrol-  and  steroid  hormone-related
inhibition in vitro  occurred  primarily  at a  site be-
tween  the flavoprotein  and  coenzyme  Q  or cyto-
chrome  b,  the  site  at  which  Amytal  is  effective
(24).  Furthermore,  they demonstrated  that under
appropriate conditions  the steroid-related  block in
electron  transport  could  be bypassed  by  the addi-
tion of high concentrations of cytochrome c or over-
come  by  the  addition  of a-tocopherol  (23,  24).
Other studies have shown that the in-vitro addition
of albumin may  restore oxidative  phosphorylation
to mitochondrial preparations treated  by the addi-
tion of a variety of uncoupling agents  (27).
A series of experiments  was, therefore,  performed
with  liver  mitochondria  from  control  and  corti-
sone-treated  animals in which the effects of various
in-vitro  additions  to  the medium  were  tested.  Al-
though  1.3  X  10
- 5 M cytochrome  c was  routinely
added  to  the  reaction  medium,  there  was  no dif-
ference in either the rates of mitochondrial respira-
tion or the P:O ratios determined  in its presence or
absence.  Higher  concentrations  of  cytochrome  c,
up to  9.0  X  10
- 5 M, likewise failed to  affect either
the  rates  of  respiration  or  the  P:O  ratios,  and
consequently  affected  neither the degree  of inhibi-
tion of respiration nor the degree of uncoupling due
to  prior  treatment  of the animals  with  cortisone.
Furthermore,  the  in-vitro  addition  of  either  ca-
tocopherol  (3.9  X  10
- 4 M),  coenzyme  Q-6  (2.9  X
10
- 4 M),  or coenzyme Q-10 (4.1  X  10
-4 M) failed  to
increase  the  rate  of  mitochondrial  respiration  or
restore normal oxidative phosphorylation  following
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either /3-hydroxybutyrate  or succinate  as  the  sub-
strate.  Bovine serum albumin in a concentration of
5  mg  per ml was  also  ineffective  in  reversing  the
abnormalities due to cortisone treatment.
The inhibition  of mitochondrial respiration  and
uncoupling  of  oxidative  phosphorylation  were
present,  but  to  a  lesser  degree,  in  mitochondria
isolated from  liver  after  6 days  of treatment  with
doses  of cortisone  as  low  as  1 mg  per  day.  Still
lower daily doses of cortisone over a 6-day period or
a single injection of 5 mg of cortisone  18 hr prior to
sacrifice were without demonstrable effect.
would have  the same measurable  characteristics  of
volume,  surface-to-volume  ratio,  and  profile  fre-
quency determined  for the actual mitochondria  in
the  electron  micrographs.  It  can  be  seen  that
cortisone  treatment increases  the size and decreases
the  number  of mitochondria  in  all  parts  of  the
hepatic lobule. The smallest mitochondria  occur in
centrilobular cells in both control and treated  rats,
while  the greatest  change  in  size  is  found  in  sec-
tions from the midzonal regions.
These measurements were  extended  in  the pres-
ent  study  by  a  quantitative  analysis  of  intra-
mitochondrial  structure,  as  described  previously
TABLE  V
Average  Cell and Mitochondrial  Dimensions
Peripheral  Midzonal  Central
Control  Treated  Control  Treated  Control  Treated
Average  cytoplasmic  volume/Cell  (nucleus)  5100  5800  5100  5800  5100  5800
(p
3)
Average  mitochondrial  characteristics
Volume per cent  of cytoplasm  19.5  22.1  20.5  24.4  15.0  15.3
A  2 Envelope/p
3 Mitochondria  7.51  5.03  7.45  4.27  10.9  7.73
Diameter ()  0.58  0.85  0.60  1.08  0.39  0.58
Length ()  3.23  6.12  2.48  3.62  4.28  2.59
No./100  3 Cytoplasm  23  6  29  7  30  23
Volume  (
3)  0.85  3.48  0.71  3.29  0.50  0.67
Quantitative Electron Microscopy
Table V summarizes quantitative morphometric
data  derived  from  a  parallel  investigation  of the
effects of cortisone  administration  on the  structure
of rat liver parenchymal cells  (16),  as it  pertains to
mitochondrial  changes  in  the  peripheral,  mid-
zonal,  and  central  regions  of the  hepatic  lobule.
Cytoplasmic  volume  is  expressed  "per  cell  (nu-
cleus)"  in Table V because  of the significant  num-
ber  of  larger  binucleate  cells  in  liver  (28);  this
approximates  the cytoplasmic volume of the aver-
age  mononucleate  cell.  Cortisone  treatment pro-
duces a small increase  in  the size  of cells  through-
out the lobules, and there is only a slight increase in
the  volume  fraction  of  cytoplasm  occupied  by
mitochondria.  The  average  size  of  individual
mitochondria,  however,  is  considerably  increased.
A  quantitative  measure  of  mitochondrial  dimen-
sions has  been  devised  with  the  assumption  that
their  general  shape  is  that  of  right  circular
cylinders  (29).  Table  V  shows  the average  diam-
eter,  length,  and  number  of such  cylinders which
for  normal  liver  mitochondria  (15).  Table  VI
shows the number of electron micrographs and the
total cross-sectional area of mitochondria that were
measured  at  a  magnification  of  50,000.  Typical
electron  micrographs  in  this  series  are  shown  in
Figs.  2-4.  Mitochondrial  volume  was  subdivided
into  three  parts:  envelope,  including  both  mem-
branes  and  any  compartment  between;  cristae,
including  the membranes  and any enclosed  space
and,  by difference,  the matrix volume.  The stand-
ard  errors  indicate  the  variation  among  the  cor-
responding  values  calculated  separately  for  each
micrograph.  The  area  of  cristae  membrane  was
measured  by  counting  the  intersections  of  mem-
brane  profile  with  a  grid  of sampling  lines super-
imposed on  the micrographs.  The total number of
such  intersections  and  the  calculated  surface-to-
volume  ratios  are  shown.  The  standard  errors  of
the  numbers  which  characterize  intramitochon-
drial  structure  indicate  the  greater  degree  of
heterogeneity  in  mitochondria  from  cortisone-
treated  animals.  A  similar  increase  in  the  vari-
68  THE  JOURNAL  OF  CELL  BIOLOGY * VOLUME  37,  1968FIGURES  2-6  Pairs  of  electron  micrographs  in  which  those  labeled  a  represent  preparations  from
control  animals  and  those labeled  b, preparations  from cortisone-treated  animals.
FIGURES  2-4  Micrographs  of peripheral-lobular,  midzonal  and  centrilobular hepatic parenchymal  cells,
respectively,  at a magnification  of 80,000. The mitochondria  in the cortisone-treated  animals  are  larger
than those in the controls for each sublobular zone of the liver. Note  also that the size of the cristae folds
is similar in  control and treated  rats, so that some  of the larger  mitochondria  in Figs.  2 b and  3 b  have
central areas that are relatively  free  of cristae.FIGURE  3 a-b  See  legend  under Fig.  .
70  THE  JOURNAL  OF  CELL  BIOLOGY  - VOLUE  37,  1968FIGURE  4 a-b  See  legend under Fig.  2.
71TABLE  VI
Intramitochondrial  Structure
Peripheral  Midzonal  Central
Control  Treated  Control  Treated  Control  Treated
Number of micrographs  4  8  5  9  5  9
Total  cross-sectional  area  of  15.1  46.7  30.2  63.3  16.8  28.8
mitochondria  (2)
Per  cent mitochondrial  volume
Envelope  13.5  9.1  13.4  7.7  19.6  13.9
(Standard error)  (0.3)  (0.6)  (1.3)  (0.8)  (0.8)  (1.1)
Cristae  29.1  26.8  24.2  19.3  32.2  28.0
(Standard error)  (0.6)  (1.8)  (1.6)  (2.0)  (1.2)  (1.8)
Matrix  57.4  64.1  62.4  73.0  48.2  58.1
(Standard  error)  (1.0)  (2.1)  (1.5)  (2.5)  (1.2)  (2.6)
Total cristae  intersections  counted  1082  2703  1696  3411  1185  1786
/2  Cristae  membrane
A3  Mitochondria  26.7  21.2  21.0  17.2  27.4  22.1
/3  Mitochondria
(Standard  error)  (1.1)  (1.4)  (1.1)  (1.8)  (1.1)  (1.3)
Total  dense  granules  counted  185  244  283  326  204  193
Dense granules
Densegranules  21.4  8.2  15.0  7.1  25.3  11.6
22 Matrix
Approximate  dense granules
A'330  130  230  110  390  180
a3  Matrix
ability of the mitochondrial  size and shape param-
eters  listed  in  Table  V  was  described  and  dis-
cussed  previously  (16).
The  electron-opaque  granules  that  are  com-
monly  seen  in  mitochondrial  matrix  were  also
counted.  An estimate of the number  of these dense
granules  per unit volume  of matrix  substance  was
calculated  with  the assumptions  regarding  section
thickness,  granule  size,  and  visibility  described
previously  (15).  With  the  increased  size  of mito-
chondria  in  cortisone-injected  rats,  the  matrix
volume  per  cent  is  significantly  increased  (p  <
0.03)  while  the relative  volume  of envelope  mem-
branes  is  decreased  (p  <  0.001).  The  volume  of
cristae,  which  are  generally  quite  flat,  is  only
slightly  decreased  (p  <  0.2)  by  cortisone  treat-
ment,  a  result  also  evident  in  the  values  for  the
area of cristae  membranes.
By the method of multiplying the figures for  the
average mitochondrial  and  cellular volumes  given
in Table V  by the  measurements  per unit volume
in Table VI, it  is possible  to characterize  the aver-
age  mitochondrion  of each  lobular  zone  and  the
mitochondrial  component of average liver  cells  as
shown  in  Table  VII.  It  is  apparent  from  these
quantitative  results  as  well  as  from  the  electron
micrographs  (Figs.  2-4)  that  the enlarged  mito-
chondria  are  not simply swollen.  The upper  part
of Table  VII emphasizes  the  increase in  all com-
ponents  that  make  up  the  larger  mitochondria
from  cortisone-treated  rats.  The  lower  part  of
Table VII,  on  the  other hand,  shows that  the in-
crease  in  volume  of the  average mitochondrion  is
accompanied  by  a  corresponding  decrease  in  the
average  number  of  mitochondria  per  cell
(nucleus).  Thus, changes in mitochondrial  charac-
teristics on  a whole-cell  basis are  relatively slight.
Although  the total  volume  of mitochondrial  sub-
stance per  cell  is  increased,  it  remains nearly  pro-
portional  to the small increase in cell  size. There  is
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74FIGURE 6 a-b  Micrographs  of negatively  stained mitochondria  from livers  of control and steroid-treated
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75a significant decrease  in the area of mitochondrial
envelope  which  is  consistent  with  the  fact  that
relatively  less  membrane  is  required  to  enclose
fewer,  but  larger  mitochondria  of the  same  total
volume.  Cortisone  administration  also  decreases
the total number of dense matrix granules.  Within
the range  of experimental  error, however,  there  is
no change in the area of cristae membranes.
Examination  of the  mitochondrial  pellets  con-
firms  the  electron  microscopic  studies  on  whole
liver  cells  and  reveals  that  mitochondria  from
cortisone-treated  animals  are  uniformly  larger
than those  from control  animals  at all correspond-
ing  levels  (Fig.  5).  In  contrast  to  the  elongated
shapes  seen  in  whole  cell  sections  (16),  the mito-
chondria  in  pellets  exhibit  the  typical  rounded
shape  following isolation in  0.25  M sucrose  at 0° C
(31). The size difference is consistent with the 50%
increase  in diameter  that would  be expected  from
the  three-to-fourfold  increase  in  volume  deter-
mined from the whole cell sections (Table V). The
negatively  stained  preparations  show inner  mem-
brane  subunits  (32)  in  mitochondria  from  both
control  and cortisone-treated  animals (Fig.  6).
DISCUSSION
The data presented in this report demonstrate  that
the  administration  of cortisone  and  other  gluco-
corticoids to rats produces a variety of biochemical
and morphological  changes  in liver mitochondria.
Mitochondrial  respiration  is  inhibited  at multiple
sites,  oxidative  phosphorylation  is uncoupled,  and
the increase  in  volume  of the  average  mitochon-
drion is accompanied  by a corresponding  decrease
in the number  of mitochondria  per cell  (nucleus).
Lowe and Lehninger demonstrated  a decrease  in
succinic  oxidase  activity  in mitochondria  isolated
from  livers of cortisone-treated  rats  (4).  The P: O
ratios  were  not  affected  by  cortisone  treatment
when  either succinate  or  glutamate  were  used  as
substrates.  It  is  noteworthy,  however,  that  the
mitochondria  from  both  normal  and  cortisone-
treated  animals  were  uncoupled,  since  the  P:O
ratios  using  succinate  as  the  substrate  were  only
0.82  and  0.85,  respectively.  While  Clark  and
Pesch  (5)  observed  a decrease  in  oxygen consump-
tion by  liver  mitochondria  from cortisone-treated
animals  with  the  use  of  ac-ketoglutarate  as  the
substrate,  the  P:O  ratios  were  not  significantly
altered.  In  these  studies  female  rats  were  treated
with lower  doses  of cortisone  over  a longer period
of  time.  Kerppola,  on  the  other  hand,  showed
that the administration  of cortisone  to rats resulted
in  both the inhibition  of oxygen  consumption and
the  uncoupling  of  oxidative  phosphorylation  in
liver  mitochondria  (6).  This  effect,  noted  with  a
variety  of  respiratory  substrates,  was  localized  at
the level  of cytochrome  oxidase  (33).  Although the
mitochondria  were  uncoupled,  there  was  no  de-
monstrable  increase  in  adenosine  triphosphatase
(ATPase)  activity.
In  the  present  study  the  decrease  in  oxygen
consumption  by  liver  mitochondria  isolated  from
cortisone-treated  animals  has  been  noted  with  a
variety  of  respiratory  substrates.  It  appears  un-
likely  that  the  decrease  in  oxygen  consumption
with exogenous substrate is simply the result of the
decreased  surface-to-volume  ratio  of the  enlarged
mitochondria,  since the mitochondria are also un-
coupled  and  are  more  sensitive  to  the  effects  of
calcium'  and  antimycin  A.  Furthermore,  the de-
fects  in  mitochondrial  respiration  have  also  been
noted  in  a  number  of  experiments  which  used
digitonin  fragments  and  sonicated  mitochondria,
with either P-hydroxybutyrate  as  the substrate  or
ascorbate  and  TMPD  as  electron  donors.  The
mitochondria  isolated  from  cortisone-treated  ani-
mals appear to have multiple defects in the respira-
tory chain.  The oxidation of ascorbate and TMPD
is  inhibited,  a  finding which  suggests  at least one
locus  of  action  in  the  terminal  portion  of  the
respiratory  sequence  between  cytochrome  c and
oxygen.  Furthermore,  the increased  sensitivity  to
antimycin  A suggests that there may be a potentia-
tion between  the effects of cortisone treatment and
the effects  of the respiratory inhibitor  at a site  be-
tween  cytochrome  b and  cytochrome  c,. In  addi-
tion, the results of the experiments with P-hydroxy-
butyrate  and  the  phenazine  methosulfate  bypass
suggest the presence of still another defect either at
the  level  of  -hydroxybutyrate  dehydrogenase  or
in  the  early  portion  of  the  electron-transport
chain.
In  addition  to  the  inhibition  of  respiration,
mitochondria  from  cortisone-treated  animals  are
uncoupled,  with lowered  P:O  ratios.  This would
suggest  either  a  decrease  in  ATP  formation  in
excess  of that anticipated  with diminished  respira-
tion, or an increase in ATP breakdown,  perhaps  as
a result of an increase in  ATPase activity.  In other
studies,'  evidence has  been obtained  that indicates
the presence  of increased  ATPase  activity in mito-
1  D.  V. Kimberg, N.  F. Goodman,  and  R.  Graudu-
sius.  Unpublished  observations.
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once again suggesting  the presence of alterations in
the inner  mitochondrial  membrane.  A variety  of
steroid  hormones  in  vitro  will inhibit  the NADH
oxidase  system  in  material  obtained  from  both
mammalian  and  microbial  sources  (23-26).  This
effect  in vitro has  been  localized  to  the  so  called
"Amytal-sensitive  step"  that  interferes  with  the
reduction  of  cytochrome  b  (24).  Many  steroid
hormones  in  vitro  have  also  been  shown  to  un-
couple  mitochondrial  oxidative  phosphorylation,
stimulate latent ATPase activity,  and cause  mito-
chondrial swelling  (34-36). However,  these experi-
ments in vitro may have little direct bearing on the
findings in  animals subjected  to in-vivo  treatment.
Treatment of rats with cortisone  and other glu-
cocorticoids has been observed to diminish both the
substrate-  and  ATP-dependent  accumulation  of
calcium  by isolated  liver mitochondria  in vitro (9,
10). As indicated by the present studies, these effects
on cation accumulation probably result from inter-
ference  with  the  utilization  of either  ATP or  the
respiratory  substrate  necessary  to support the up-
take  process.  The dense granules  in the  matrix of
mitochondria  have been implicated  as sites of cal-
cium  deposition  (37).  Of  interest  then  was  the
finding  (Table  VI)  that mitochondria  in  sections
of  liver  from  steroid-treated  animals  contained
one-half  of the control  number of dense  granules
per unit volume  of matrix.
It was suggested  as early as  1955  that cortisone
treatment in  the rat may be responsible  for both a
decrease in the number of mitochondria  in hepatic
parenchymal  cells  as  well  as  an  increase in mito-
chondrial  size  (8).  Both quantitative  and electron
microscopic  observations  concerning  such  altera-
tions have,  however, heretofore  been lacking.  The
increase  in the volume of individual mitochondria
and the commensurate decrease  in the number per
cell are present in parenchymal cells in  all regions
of the liver lobule.  The  morphological  alterations
are  most marked,  however,  in  the  midzonal cells.
The  total  mitochondrial  volume  per cell  and  the
per cent of the total cytoplasmic volume occupied
by  mitochondria  remain  relatively  unaltered,  as
does  the total amount of cristae  surface per cell. It
is  important to note  that there is an increase in  all
of the components  that make  up  the larger  mito-
chondria  from cortisone-treated  rats  (Table VII),
and hence, while these mitochondria are enlarged,
they are not simply swollen as previously  suggested
(8).  After  6  days  of cortisone  treatment  there  is
only a slight increase in hepatic cell size  and little,
if any, difference in the total amount of mitochon-
drial protein derived from the livers of control and
treated  animals.  The fact  remains,  however,  that
following  cortisone  treatment  mitochondria  are
larger and fewer in number; moreover,  these mito-
chondria  are biochemically  defective.
The  precise  mechanism  by  which  cortisone
treatment  causes  biochemical  and  morphological
changes,  and whether these changes  are  related to
each  other in hepatic  parenchymal  cell mitochon-
dria,  are not  known.  Many  of the  hormonal  in-
fluences  on mitochondria  noted in this  study may
be due  to  a direct  interaction  with  the mitochon-
drion  or, alternatively,  may  be secondary to  other
effects of cortisone on cell metabolism.  The finding
of a diminished number of mitochondria per cell in
parallel  with  an  increase  in their average  volume
may be the result of mitochondrial fusion or failure
to  replicate  with  continued  growth  of some  mito-
chondria. The basis for the morphological  changes
within  the  mitochondrion  must  await  a  clearer
understanding  of the factors regulating  mitochon-
drial genesis,  growth,  and turnover  in mammalian
cells.
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